NDC 0006-5034

Ontruzant

Ontruzant

Ontruzant is a Intravenous Kit in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is .

• Product ID: 0006-5034_251cf6e9-46e5-419e-bbbc-12c914ccc7fc
• NDC: 0006-5034
• Product Type: Human Prescription Drug
• Proprietary Name: Ontruzant
• Generic Name: Ontruzant
• Dosage Form: Kit
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-04-15
• Marketing Category: BLA / BLA
• Application Number: BLA761100
• Labeler Name: Merck Sharp & Dohme Corp.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0006-5034-02

1 KIT in 1 CARTON (0006-5034-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, MULTI-DOSE * 1 INJECTION, SOLUTION in 1 VIAL

• Marketing Start Date: 2020-04-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0006-5034-02 [00006503402]

Ontruzant KIT

• Marketing Category: BLA
• Application Number: BLA761100
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2020-04-15

Drug Details

OpenFDA Data

• SPL SET ID: a8d34591-b709-492b-84e3-d7764db9366a
• Manufacturer:
  • Merck Sharp & Dohme Corp.
• UNII:
  • P188ANX8CK
• RxNorm Concept Unique ID - RxCUI:
  • 2289232
  • 2289234
  • 2289237
  • 2289227
• UPC Code:
  • 0300065034027

NDC Crossover Matching brand name "Ontruzant" or generic name "Ontruzant"

NDC	Brand Name	Generic Name
0006-5033	Ontruzant	trastuzumab
0006-5034	Ontruzant	Ontruzant
78206-147	Ontruzant	trastuzumab
78206-148	Ontruzant	Ontruzant